Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma 39 Lymphoma 38 Lymphoma, Large B-Cell, Diffuse 28 Lymphoma, Non-Hodgkin 22 Osteosarcoma 15 Burkitt Lymphoma 14 Hodgkin Disease 13 Testicular Neoplasms 11 Recurrence 9 Leukemia 9 Neuroectodermal Tumors, Primitive, Peripheral 8 Lymphoma, Large-Cell, Immunoblastic 8 Lymphoma, Follicular 8 Lymphoma, B-Cell, Marginal Zone 8 Teratoma 7 Ovarian Neoplasms 7 Lymphoma, Mantle-Cell 7 Leukemia, Lymphocytic, Chronic, B-Cell 7 Testicular Germ Cell Tumor 6 Precursor Cell Lymphoblastic Leukemia-Lymphoma 6 Neuroblastoma 6 Carcinoma, Embryonal 6 Breast Neoplasms 6 Rhabdomyosarcoma 5 Lymphoma, Large-Cell, Anaplastic 5 Endodermal Sinus Tumor 5 Central Nervous System Neoplasms 5 Urinary Bladder Neoplasms 4 Neoplasms, Germ Cell and Embryonal 4 Lymphoma, B-Cell 4

Interventions

Diathermy 5 Radiotherapy 2 Immunotherapy 2 Immune Checkpoint Inhibitors 2 Cisplatin 2 tislelizumab 1 sodium thiosulfate 1 anlotinib 1 Surgical Procedures, Operative 1 Radiation Dose Hypofractionation 1 Radiation 1 Laparotomy 1 Ifosfamide 1 Fluorouracil 1 Drug Therapy 1 Doxorubicin 1 Docetaxel 1 Dacarbazine 1 Cytoreduction Surgical Procedures 1 Chemoradiotherapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Hyperthermia × Ifosfamide × Clear all

NCT06835049 2025-12-30

TNT-HYPE

Swiss Cancer Institute

Phase 2 Recruiting

Hyperthermia, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡